Summary
The role of postoperative radiation therapy in stage III non–small cell lung cancer treatment remains undetermined. Multidisciplinary discussion with up-front stratification in potentially resectable or unresectable disease is of key importance. Factors such as surgery type and hospital volume are key to surgical outcomes.
- stage III non–small cell lung cancer
- adjuvant chemotherapy
- neoadjuvant chemotherapy
- induction chemotherapy
- postoperative radiation therapy
- chemoradiation therapy
- induction chemoradiation therapy
- oncology clinical trials
- adjuvant/neoadjuvant therapy
- © 2015 SAGE Publications
Tools
Factors Affecting Use of PORT, Induction Chemotherapy, and Surgery to Improve Outcomes in NSCLC
Permalink:
Table of contents
Cited By...
- No citing articles found.